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ABSTRACT We have examined the regulation of maturation-promoting factor (MPF) activity
in the mitotic and meiotic cell cycles of Xenopus laevis eggs and oocytes. To this end, we
developed a method for the small scale extraction of eggs and oocytes and measured MPF
activity in extracts by a dilution end point assay. We find that in oocytes, MPF activity appears
before germinal vesicle breakdown and then disappears rapidly at the end of the first meiotic
cycle. In the second meiotic cycle, MPF reappears before second metaphase, when maturation
arrests. Thus, MPF cycling coincides with the abbreviated cycles of meiosis. When oocytes
are induced to mature by low levels of injected MPF, cycloheximide does not prevent the
appearance of MPF at high levels in the first cycle. This amplification indicates that an MPF
precursor is present in the oocyte and activated by posttranslational means, triggered by the
low level of injected MPF. Furthermore, MPF disappears approximately on time in such
oocytes, indicating that the agent for MPF inactivation is also activated by posttranslational
means. However, in the absence of protein synthesis, MPF never reappears in the second
meiotic cycle. Upon fertilization or artificial activation of normal eggs, MPF disappears from
the cytoplasm within 8 min. For a period thereafter, the inactivating agent remains able to
destroy large amounts of MPF injected into the egg. It loses activity just as endogenous MPF
appears at prophase of the first mitotic cycle. The repeated reciprocal cycling of MPF and the
inactivating agent during cleavage stages is unaffected by colchicine and nocodazole and
therefore does not require the effective completion of spindle formation, mitosis, or cytoki-
nesis. However, MPF appearance is blocked by cycloheximide applied before mitosis; and
MPF disappearance is blocked by cytostatic factor. In all these respects, MPF and the
inactivating agent seem to be tightly linked to, and perhaps participate in, the cell cycle
oscillator previously described for cleaving eggs of Xenopus laevis (tiara, K., P. Tydeman, and
M. Kirschner, 1980, Proc. Nati. Acad. Sci. USA, 77:462-466).
There is compellingcircumstantial evidence that maturation
promoting factor (MPF)' is a cytoplasmic agent responsible
for the initiation ofthe meiotic or mitotic phase (M phase) of
the eucaryotic cell cycle. This factor was first detected in
unfertilized amphibian eggs, from which cytoplasm was with-
drawn and microinjected into full grown amphibian oocytes,
'Abbreviations used in this paper:
￿
EB, extraction buffer, containing
80 mM sodium ß-glycerolphosphate, pH 7.3, 15 mM MgC12, 20 mM
sodium EGTA; EB-SATP, EB containing 0.3 mM -y-thioATP;
GVBD, germinal vesicle breakdown; MPF, maturation-promoting
factor; MR medium, modified Ringer's, containing 100 mM NaCl,
1.8 mM KCI, 2 MM CaC12, 1 MM MgC12, 4 mM NaHC03.
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causing the oocytes to "mature" into unfertilized eggs, hence
the name ofthe factor (for reviews, see references 13, 15, 23).
In terms of the cell cycle, such eggs are naturally arrested at
second meiotic metaphase, making them a convenient source
of M phase cytoplasm, whereas oocytes are naturally arrested
in G2 or early meiotic prophase and lack active MPF, making
them convenient recipients. A small injection of M phase
cytoplasm causes the G2 cell to initiate M phaseprecociously,
independent of the normal stimulus by progesterone, and to
complete maturation even to the extent of forming normal
high levels of MPF, which can be detected by serial transfer
of cytoplasm to yet another nonmatured recipient (21). More
recently, MPF has been extracted in active form from oocytes,
1247M phaseamphibian eggs during cleavage (27), starfish oocytes
and eggs (11), mammalian cultured cells (HeLa [24] and
Chinese hamster ovary [19]) and cdc mutants of yeast (28),
but not from interphase cells, as assayed in all cases by
injection of the extract into amphibian oocytes to induce
maturation. Because ofits ubiquitous presence in mitotic and
meiotic cells, the factor can be referred to as an "M-phase
promoting factor," rather than just a maturation-promoting
factor.
Partial purification of the Xenopus egg MPF has been
accomplished; the factor behaves as a protein -100 Walton
(kD) size (3, 26, 29). Its action as an M phase initiator is
thought to depend on its ability to activate a cascade of pre-
formed enzymes executing the specific processes of mitosis,
such as nuclear membrane breakdown, chromosome conden-
sation, and spindle formation. In support of this view, it is
known that partially purified MPF can initiate the early events
of M phase when injected into cycloheximide-inhibited Xen-
opus oocytes (29), or cleaving embryos (18), indicating that
at least some of the agents needed for the execution of M
phase are present in a latent but activatable form.
In our study, we were interested in the cell cycle dependent
regulation of MPF activity. MPF activity appears at the late
G2 phaseofthe cell cycle and disappears at the end ofmitosis.
Ultimately, we would like to trace this phase-specific pattern
ofMPF activity to the oscillatory processes postulated to drive
the cell cycle itself(8, 12). Recently, Hara et al. (6) found that
aspects of the cell cycle persist in anucleate, noncleaving,
colchicine-inhibited activated eggs. Namely, such eggs con-
tinue to undergo regular surface contraction waves on the
schedule of the cell cycle, even though they cannot complete
DNA synthesis, spindle formation, chromosome condensa-
tion, or cytokinesis. These authors suggest that these dispen-
sable events must be classified as effects of the underlying
oscillators driving the cell cycle, and not as elements of the
oscillatory reactions themselves. Earlier, MPF activity had
been found to cycle in activated, noncleaving eggs (27), a
result that we now interpret to mean that MPF is closely
linked to the oscillator, rather than to any of the various
dispensable events ofthe cell cycle. On the other hand, there
are two published results that indicate a separation of MPF
activity from the cycling of the cell. If verifiable, these results
would lead us to conclude that MPF cycling is itself a dispen-
sable event of the cycle. First, Wasserman and Smith (27)
report that MPF activity remains high and constant in col-
chicine-blocked eggs, whereas the oscillators are known to
continue to cycle in such eggs (6). Second, Masui et al. (17)
have mentioned that cleaving eggs arrested in mitotic meta-
phasewith cytostaticfactor (the cytoplasmic agent thought to
arrest unfertilized eggs in meiotic metaphase) do not accu-
mulate MPF, whereas one would expect MPF to be present
in this M phase cell. To examine the relation of MPF to the
cell cycle under a variety of conditions, we developed a small
scale extraction procedure and an endpoint dilution assay for
MPF. In contradiction to these previous exceptions, we report
that in all cases where the cell cycle continues to function,
MPF continues to cycle, whereas in cases where the cycle is
blocked, MPF activity is held at the corresponding high or
low level characteristic of that stage of the cycle. Thus, the
pattern of MPF activity seems to be tightly linked to the cell
cycle oscillator.
With this self-consistency of results for MPF regulation in
the cell cycle, we can turn to the oocyte for more detailed
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information on the actual steps of MPF activation (see Masui
and Clarke [ 15] for a review). Two steps have been distin-
guished in maturing oocytes; one, a step in which an uniden-
tified factor activates a small amount of MPF, and second,
an amplification step in which MPF becomes auto-activating
to produce high levels ofitself. The first step seems clearly to
require protein synthesis, since a variety of agents including
progesterone, the hormone normally stimulating meiosis in
the oocyte, fail to elicit MPFactivation and oocyte maturation
in the presence of inhibitors of protein synthesis, such as
cycloheximide. It remains to be seen whether this protein-
synthesis-requiring step is peculiar to the MPF activation
process ofthe oocyte, or is general to any cell cycle which, as
in the case of the oocyte, has to advance to a point where
MPF can be activated. Indeed, Miake-Lye et al. (18) have
found that protein synthesis is necessary for the forward
progress of the cell cycle ofthe cleaving egg.
The second step in MPF activation, according to previous
reports, may or may not require protein synthesis, and a
correct resolution ofthe issue is important for our understand-
ing of the MPF activation process. On the one hand, Drury
and Schorderet-Slatkine (4) conclude that MPF autoamplifi-
cation does not occur in cycloheximide-inhibited oocytes
injected with small amounts of MPF. On the other hand,
Wasserman and Masui (25) conclude the opposite in rather
similar experiments. We report here than protein synthesis is
not required for the amplification step in oocytes and that the
previous discrepancies are due to the fact that MPF activity
oscillates in the meiotic cycle. Therefore, MPF is amplified
by posttranslational mechanisms operating on a pool ofMPF
precursor.
MATERIALS AND METHODS
Materials:
￿
Adult Xenopus taevis femalesand males were obtained from
C. Sullivan (Nashville, TN), Nasco Co. (Modesto, CA), or raised in the
laboratory. Females were injected each with 20-50 units of pregnant mare
serum gonadotropin (PMSG; CalBiochem-Behring Corp., San Diego, CA) 3 d
before the surgical removal of ovary for use of manually dissected oocytes in
the injection assay of MPF levels. Generally oocytes were used on the day of
removal. Eggs were obtained from females injected 1-3 d earlier with 50 units
PMSG, and 8-12 h earlier with human chorionicgonadotropin (Sigma Chem-
ical Co., St. Louis, MO). General procedures for the handling of eggs and
oocytes have been described (14, 20, 29). MPF was partially purified from
extracts ofunfertilized eggs, as described by Wu and Gerhart (29), except that
the arginine agarose step was omitted and replaced with a fractional precipita-
tion with 6% polyethylene-glycol 6000 (Sigma Chemical Co.). Cytostatic factor
was obtained by injecting 50 nl of 10 mM sodium EGTA, pH 7.0, into an
unfertilized egg, from which -250 nl ofcytoplasm were then withdrawn in the
same needle (9). This cytoplasm was then injected 50 nl each into five fertilized
eggs, to block them at mitotic metaphase (17). Cycloheximide, puromycin, and
nocodazole were obtained from Sigma Chemical Co.; diphtheria toxin was a
gift from Dr. J. Maller (University of Colorado, Denver).
Methods:
￿
Before extraction, eggs were incubated in 5% Ficoll 400
(Sigma Chemical Co.) in 20% MR medium (modified Ringer's containing 100
mM NaCl, 1.8 mM KCI, 2 mM CaC12, I MM MgC12, 4 mM NaHCOA to
shrinktheperivitellinespace and reduce the residualvolume ofmedium carried
over into the extraction step. This precaution was not necessary for oocytes
since they lack a perivitelline space. For the preparation of small volumes of
extract, seven eggs or oocytes were rinsed in ice cold EB (extraction buffer
containing 80 mM sodium 0 glycerol phosphate, pH 7.3, 15 mM MgC12, 20
mM sodium EGTA) and collected in a small cluster on a parafilm layer on a
cooled aluminum block (0°C). Excess EB was removed from the cluster and
then 7 Al EB-SATP(EBcontaining0.3 mM y-thioATP [Boehringer Mannheim
Biochemicals,Indianapolis, IN]) were added;immediatelythe cellswerebroken
in an Eppendorf pipette tip and homogenized by several passages of the
suspension in and out ofthe tip. Various dilutions were immediately prepared
from the extract, generally to a furthertwo- and fourfold extent, by mixing the
appropriate volumes of extract and EB-SATP. Each homogenate or dilutionwasdrawn into one-halflengthofa 40-tul microcaptube(DrummondMicrocap
Co., Oakland, CA) which had been pre-melted almost to closure at one end.
The tube containing the homogenate was carefully flamed to complete closure
ofone end, andwascentrifuged for 15 min at top speed inaBeckman Microfuge
(Beckman Instruments, Palo Alto, CA), to sediment yolk to the bottom and fat
to the top. The tube was then scored with a glass file and broken just beneath
the fat layer, so that the clear homogenate could be drawn into the injection
needle. In general, five oocytes were injected each with 40 nl ofextract, for a
singleassay point, and scored forgerminal vesicle breakdown (GVBD) after 2-
2.5 h. The injection and scoring procedures have been described (14, 29) and
were used with minor modifications given in the figure legends ofthis article.
Eggs were fertilized in vitro with testis homogenate, dejellied in 2.5%
cysteine, pH 7.9, and washed extensively in 20% MR medium, as described
previously (5, 20). Eggs were chosen on the basis ofthe dark sperm entrance
point to assure fertilization. Dejellied unfertilized eggs were activated by needle
puncture or by electric shock (12 V, I s, across a 3-cm distance, eggs in 20%
MR medium).
For the staging ofoocytes in meiosis, the following procedure was followed.
Oocytes were injected with 5 units of partially purfied MPF (20 ng protein in
40 Al EB containing 1 mM ATP) and incubated at 23°C. GVBD occurred 65-
70 min later in the majority of the oocytes and the remaining tardy oocytes
were eliminated. Then, at 10- or 15-min intervals, oocytes were removed and
fixed in 10% formaldehyde (by volume from a 37% stock) in 0.06 M sodium
HEPES, pH 7.4, for at least 2 h, after which Hoechstdye 33258 (bisbenzimide;
Sigma Chemical Co.) was added to a concentration of 5 ug/ml. Staining was
allowedto proceed for several hours and thena200-temsquare patch containing
the "white spot" at the animal pole ofthe oocytewas dissectedwith watchmak-
er's forceps in a solution containing 50% glycerol, 0.1 M Tris-HCI, pH 7.5, 2%
n-propyl gallate, and 10% ethanol. The vitelline membrane, follicle cells, and
excess yolk were removed from the patch, which was then mounted in a drop
of the same medium on a slide with coverslip. The plasma membrane side of
the patch was oriented uppermost. The Hoechst-stained chromosomes were
visualized by epi-illumination on a Zeiss photomicroscope III, and were pho-
tographed througha Leitz neofluar 63x lens, with Kodak Pan 2415 film, which
was developed with HC 110 dilution D. The meiotic stage of the oocyte was
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FIGURE 1
￿
Cycling of MPF activity in artificially activated eggs of X.
laevis, and arrest of that cycling by cycloheximide. Unfertilized eggs
were dejellied in cysteine, washed in MR medium, and incubated
at 19°C in MR medium with (*) or without (0) cycloheximide at
200 ug/ml, for 60 min. They were then activated by electric shock
(12-V, 1-s, 3-cm separation of electrodes) and incubated in 20%
MR-5% Ficoll. At each indicated time, a group of seven eggs was
removed, washed, homogenized, and diluted two-, three-, or four-
fold as described in Materials and Methods. The arrows marked I"
and 2nd indicate the times of first and second cleavage in a set of
fertilized eggs from the same frog. The axis indicating time is defined
with 0.0 at fertilization and 1 .0 at first cleavage for a set of fertilized
eggs (112 min at 19°C); for activated eggs, activation is set at 0.0
and sampling times are normalized to the 112-min interval. The
units for MPF activity are defined in the Results section. The plateau
of activity at 105 units per egg is a limit set by the greatest dilution
used in the assay. The maximum activity never surpasses 135 U/
egg, as shown in Fig. 3.
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FIGURE 2
￿
Cycling of MPF activity in fertilized eggs of X. laevis, and
the arrest of that cycling by cytostatic factor. Eggs were fertilized in
vitro, dejellied with cysteine, washed three times with 20% MR
medium, and incubated at 19.5°C in 20% MR-5% Ficoll, to prevent
swelling of the perivitelline space. At the indicated times, seven
eggs were removed as a group, washed briefly in ice cold EB, and
homogenized with 7 t<I EB-SATP as described in Materials and
Methods. Dilutions of two-, three-, and 4.5-fold were prepared at
times when high MPF activity was expected. Cleavage occurred at
108 min. The time scale is normalized to the interval from fertiliz-
ation (0.0) to first cleavage (1 .0). Some eggs (0) were injected each
(in the 0.5-0.7 period of the first cell cycle) with 50,ul of cytoplasm
from unfertilized eggs blocked from activation by EGTA, as de-
scribed in Materials and Methods, whereas others served as control
(0). The arrows marked I" and 2"d indicate the time of first and
second cleavage in controls. The upper limit of assayable activity is
120 U/egg, set by the greatest dilution used in this experiment. The
maximum activity of MPF in eggs never surpasses 135 U/egg, as
shown in Fig. 3.
inferred from the thickness and arrangement of the chromosomes, and by
comparison with the stages of Huchon et al. (7).
MPF Dynamics after Fertilization or Activation
Our small scale extraction method allowed us to quantify
the appearance and disappearance ofMPF in the first few cell
cycles, with an accuracy not previously attained. We define a
unit of MPF activity as that amount causing a 50% frequency
of germinal vesicle breakdown in oocytes injected each with
a volume of 40 nl of test material. (This definition differs
slightly from the one given previously [29] in terms of the
volume injected.) As shown in Figs. 1 and 2, MPF is present
in unfertilized eggs at a level ofat least 100 units per egg; that
is, if a single egg is extracted in a volume of 4 IAl, the extract
will contain enough MPF to inject 100 oocytes with 40 nl
each, and obtain 50% frequency of maturation. The volume
of 4 lul is calculated from the end point in the dilution series
prepared for the extract. The MPF activity in unfertilized eggs
is actually 120-140 units per egg (see Fig. 3), but the upper
limit in Figs. 1 and 2 is set at 105 units per egg by the greatest
dilution used in these particular experiments.
When eggs are activated by needle puncture or electric
shock, to release them from their arrest in second meiotic
metaphase, MPF activity drops to undetectable levels within
8 min afteregg activation. The lowerlimit of detection in our
assay is - 15 units per egg, due to the inherent dilution of the
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1249homogenate itself. Because the inactivation of MPF is so
rapid, it was only possible to measure the time course after
electrical activation, where large numbers ofdejellied eggs can
be activated synchronously and sampled immediately, as
shown in Fig. 1.
MPF inactivation probably occurs rapidly in fertilizedeggs
as well,since MPF is undetectable at 20 min postfertilization,
the earliest time ofsampling after fertilization and dejellying.
Then, MPF abruptly reappears at approximately two-thirds
of the time through the first cell cycle. For an accurate
comparison of cell cycle times in eggs at different tempera-
tures, we have adopted a normalizedscale, where fertilization
or activation is set at 0.0 and first cleavage at 1.0. At 19.5°C,
this interval would cover 108 min. On this normalized scale,
second cleavage would occur at 1 .4. The activation of MPF
in the first cycle is seen at 0.65, as shown in Fig. 2, and MPF
inactivation follows at 0.85. That is, within a 20-min period
at 19.5°C, MPF returns to levels as high as in unfertilized
eggs, and then disappears as rapidly as it did upon egg acti-
vation. The maximum point at 0.8 corresponds closely to the
time of the "surface contraction wave" of the egg, approxi-
mately at the time ofthe mitotic metaphase-anaphase transi-
tion (10).
The second cell cycle shows similar dynamics of MPF(Figs.
2 and 3), as do later cycles, measured out to the seventh
cleavage (data not shown). The MPF oscillations appear to
damp out slightly as cleavage continues, perhaps because of
the slight metachrony (asynchrony) of the cell cycles in differ-
ent regions of the cleaving egg. However, MPF cycling is still
apparent even at the seventh cleavage. These latercycles have
the short period characteristic ofthe observed cleavages (-30-
min intervals).
It is the first cell cycle that is unique from the other cycles
in having a prominent G2-like phase, that is, a long delay
between the completion of DNA synthesis and the start of
mitosis (18). This is reflected in the long period between MPF
disappearance at fertilization and reappearance before first
cleavage. As shown in Fig. 1, the pattern of MPF activity is
somewhat different in activated eggs in the first cell cycle,
compared to fertilized eggs. MPF appears much earlier in the
first cycle, by 0.30 rather than 0.65, that is, with no delay
between DNA synthesis and MPF appearance. Furthermore,
in activated eggs, MPF decreases somewhat later. However,
MPF cycling in the second and third cycles in these eggs is
clearly demonstrable with a periodicity similar to that in
fertilized eggs.
In an effort to evaluate the importance ofprotein synthesis
for these cycling events, we treated unfertilized eggs with
cycloheximide and found that MPF levels remain high, even
for a 2-h period (data not shown), provided that activation
does not occur. This indicates that MPF does not turn over
by a process of protein synthesis and breakdown in unfertil-
ized eggs arrested in metaphase. When cycloheximide-in-
hibited eggs are electrically activated, they destroy MPF activ-
ity with the same kinetics as in control eggs (Fig. 1), indicating
that the MPF-inactivatingsystem alsodoes not require protein
synthesis for its operation, but must be present, stable, and
poised in an inactive form in the unfertilized, metaphase-
arrested egg. It was found, however, that cycloheximide
treated activated eggs could not restore MPF activity in the
0.30-0.90 period (Fig. 1), as if protein synthesis was needed
to prepare new MPF precursors or to advance the cell cycle
to the point ofendogenous MPF activation. Miake-Lye et al.
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FIGURE 3
￿
Cycling of MPF in nocodazole-treated fertilized eggs of
X. laevis. Unfertilized eggs were incubated in MR medium with (0)
or without (p) nocodazole, 10 ug/ml, for 60 min, and then fertilized
in vitro, dejellied in cysteine, washed in 20% MR medium, and
incubated at 19°C in 20% MR-5% Ficoll, with or without nocoda-
zole. At each time indicted, a group of seven eggs was removed,
homogenized, diluted two-, 3.5-, or fivefold, and assayed for MPF
activity as described in Materials and Methods. The axes are defined
in the legends of Fig. 1 and 2, and in the text. The upper limit of
assayable MPF activity is -150 U/egg, that is, in excess of the
highest measured activity of 135 U/egg.
(18) have reported that the cell cycle timing of the surface
contraction wave is also effectively blocked in cycloheximide
treated eggs, which arrest in a G2-like phaseafterthe comple-
tion of DNA synthesis.
Effect of Cell Cycle Inhibitors on MPF Cycling
Fertilized eggs were incubated in solutions ofthe microtu-
bule-depolymerizing drug, nocodazole, at concentrations 30-
fold in excess of that needed to block cleavage. Nonetheless,
as shown in Fig. 3, MPF continues to cycle with the same
periodicity as in control eggs. However, in nocodazole-
blocked eggs, MPF appears at 0.50, -0.15 time units earlier
than in control eggs, and disappears -0.10 units later. In this
respect of timing, the nocodazole-treated egg partially resem-
bles the artificially activated egg. The related drug, colchicine,
was injected (10 mM stock; 40 nl injected per egg) at levels
50 times above that needed to block cleavage, and MPF was
found to cycle nonetheless (data not shown). As a general
conclusion, it can be said that contrary to a previous report
by Wasserman and Smith (27), MPF cycling was not arrested
nor was MPF held indefinitely at a high level in the presence
of antimicrotubule drugs. We cannot explain the discrepancy
of the previous and present results, except to note that the
previous studies were done with Rana pipiens eggs and that
the assay method relied on direct cytoplasmic transfer rather
than extraction. However, it remains to be seen what underlies
the discrepancy. This demonstrated inability of nocodazole
and colchicine to block the cycling of MPF in the egg, while
interfering with spindle formation and furrow formation, is
consistent with the findings of Hara et al. (6) that the periodic
surface contraction wave continues to appear on time, unhin-
dered by vinblastine or colchicine. It seems clear that anti-microtubule drugs have a much more limited effect on the
cell cycle in the egg compared to their effect in somatic cells
(19), but we do not understand the bases for this difference.
In contrast to the ineffectiveness ofthese antimitotic drugs,
the metaphase arrest factor (cytostatic factor) obtained from
the cytoplasm of unfertilized eggs, is completely effective in
blocking the cycling ofMPF when injected into fertilizedeggs
in the middle (0.5 to 0.7) of the first cell cycle. Such injected
eggs produce MPF on the normal schedule, and then fail to
cleave. As shown in Fig. 2, they maintain for at leastan hour
a high level of active MPF characteristic of metaphase cells.
It is known that such eggs contain condensed metaphase
chromosomes on a spindle (16) and fail to initiate a surface
contraction wave (Newport, J., K. Butner, and M. Kirschner,
personal communication). Control experiments have shown
that fertilized eggs injected with 50 nl of2 mM EGTA (a level
comparable to that present in our cytostatic factor material)
do not block cleavage or keep MPF activity at elevated
noncycling levels. By all these criteria, cytostatic factor ap-
pears to arrest eggs in a true metaphase state, including the
presence of MPF at high mitotic levels.
MPF-inactivating Factors in the Cell Cycle
As presented already in Fig. 1, MPF activity disappears
within a few minutes afteregg activation, due presumably to
an MPF-inactivating agent that is stable and latent in the
unfertilized egg and activated rapidly at fertilization or egg
activation. We have assayed this agent in vivo by injecting
large amounts ofpurified MPF into activated eggs at various
times in the first cell cycle, and then extracting the injected
eggs 10 min laterto quantify the remaining MPF. For exam-
ple, when fertilized eggs are each injected with 80-100 units
of MPF, the MPF is totally inactivated (within the sensitivity
of the assay, >85% inactivation) within 10 min in eggs in the
time period of 0.3-0.6 of the first cell cycle. That is to say,
the inactivating agent persists at high levels throughout the
interval from fertilization to 0.6, when endogenous MPF
becomes detectable before first mitotic prophase. When the
injected MPF is assayed afterjust 5 min in the fertilized egg,
it is also found that MPF is totally inactivated except at the
time 0.55, that is, a few minutes before endogenqus MPF
appears. At this time, the injected MPF is only half-inacti-
vated, an indication ofa decline in MPF-inactivating activity.
Of course, in the 0.6-0.85 period when endogenous MPF
activity is high, the activity ofthe inactivating agent is presum-
ably low; however, we cannot quantify the exact level by our
injection assay because of the high background activity of
endogenous MPF. In conclusion, the 0.0-0.6 period of the
first cell cycle is characterized by a high level of an MPF-
inactivating agent that is itself activated at fertilization and
inactivated at the start of the first mitotic phase.
MPF-cycling in Maturing Oocytes
Full grown oocytes were injected each with 5 units of
partially purified MPF (20 ng protein) to induce meiotic
maturation. This amount exceeds approximately five times
that needed for maturation at a 50% frequency, and causes
rapid synchronous maturation in 100% of the recipients. At
intervals within the subsequent 4 h, samples of oocytes were
taken for homogenization and assay of the level of MPF
produced during maturation. The background level of in-
jected MPF is undetectable in our assay, but endogenously
60 160 240
minutes
FIGURE 4 MPF activity during oocyte maturation. Docytes were
incubated for 60 min in MR, with (9) or without (p) 20 pg/ml
cycloheximide. Then they were injected each with 5 units of
partially purified MPF (20 ng protein) in 40 nl EB containing 1 mM
ATP (time 0) and incubated at 19°C. The cycloheximide-treated
oocytes, after MPF injection, underwent germinal vesicle break-
down (GVBD) in half the population at 85 min postinjection,
whereas the nontreated oocytes reached 50% GVBD at 75-min
postinjection. These times are indicated by the arrows and respec-
tive symbols. At the times indicated, five oocytes were removed as
a group, washed briefly in ice cold EB, and homogenized with 5 pl
EB-SATP as described in Materials and Methods. Dilutions of two-,
three-, or fourfold were prepared at times where high activity was
expected. Under the conditions of assay, 105 units of MPF per
oocyte is the upper limit of assayable activity. The maximum MPF
activity detected in oocytes, when greater dilutions were done, is
135 U/oocyte. As a separate experiment, oocytes were exposed to
progesterone, 1 jug/ml in MR, and at the time of GVBD oocytes
were selected in groups reaching GVBD within 5 min of one
another, to achieve synchronization. Then, at regular intervals,
groups of these oocytes were removed, homogenized, and diluted
as described previously, and assayed for MPF activity (p). These
time points are placed on the time scale, with GVBD arbitrarily set
at 80 min, for comparison with the time course of MPF-induced
maturation.
produced MPF becomes readily detectable within 30 min
after injection. The level of MPF continues to increase to at
least 100 units per oocyte, that is, approximately 100 times
the minimal necessary injected dose, as shown in Fig. 4. After
GVBD at 70-80 min, the MPF level remains high until 120
min. After thistime, the leveldropsprecipitously and becomes
undetectable at 160 to 170 min at 19°C. Thereafter, it in-
creases again and finally reaches a plateau of 100 units per
oocyte by 240 min. This level is maintained for many hours
and is that found in unfertilized eggs.
This pattern of rapid MPF cycling during meiotic matura-
tion has not been observed previously. In the early studies of
progesterone-matured amphibian oocytes (16, 26), it would
probably have been difficult to observe cycling because the
population response of the oocytes is usually heterogeneous
in time and because the previous assays were too qualitative.
To see ifMPF goes through cycles in progesterone stimulated
oocytes, we picked out a subpopulation of oocytes which had
reached GVBD within a 5-min interval, -3 h afterprogester-
one exposure (1 fzg/ml of MR). These oocytes were then
extracted at closely spaced time intervals over the next 2 h.
They indeed showed a disappearance of MPF at 50 min post-
GVBD at 19°C, and a subsequentreappearance to -100 units
per oocyte shortly thereafter, as shown in Fig. 4. Thus, cycling
of MPF occurs in both progesterone-induced and MPF-in-
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the progesterone-induced oocytes seem to complete the MPF
cycling slightly more rapidly than do MPF-induced oocytes.
We focused on the possibility that the cycling of MPF
activity in maturing oocytes reflects the first and second
meiotic cycles, and therefore we attempted to correlate cyto-
logical staging of oocytes with our MPF measurements. There
is only limited cytological information on the timing of
meiotic stages in X. laevis (1, 7), and consequently we needed
to develop our own normal series for MPF-injected oocytes.
To this end, we fixed oocytes in formaldehyde at various
times after MPF injection, and stained the meiotic chromo-
somes with Hoechst dye 33258 (bisbenzimide). The animal
pole was dissected from the oocyte and mounted under a
coverslip for observation of the fluorescent chromosomes by
epi-illumination, as described in Materials and Methods. At
23°C, the injected oocytes reach GVBD by 65-70 min. There-
after, as indicated by our cytological analysis, the first meiotic
cycle is probably complete by 110-125 min, with second
meiotic metaphase reached at 140 min after MPF injection
at this temperature, as shown in Fig. 5. From the same series
of injected oocytes, samples were taken for MPF assay, and it
was found that MPF disappeared abruptly at 110-125 min
after MPF injection, and rose to full activity again by 140
min. Thus, our findings suggest that the cycling of MPF does
indeed reflect the progress of the two meiotic cell cycles, with
MPF low at time of meiotic interphase. It is noteworthy for
comparison that the disappearance and reappearance ofMPF
at the meiotic interphase, although rapid, is actually less rapid
than occurs in the mitotic cycles after fertilization (see the
second cycle of Fig. 2).
Effects of Protein Synthesis Inhibition on MPF
Cycling in Maturation
When the above experiments were repeated with cyclohex-
imide treated oocytes, it was found that MPF-injection (5
units per oocyte) could nonetheless induce maturationat least
to the stage of GVBD, as has been observed previously by
others (4, 25). We find that MPF levels increase at approxi-
mately the same rate as in control oocytes (no cycloheximide),
and reach an activity of 75 units per egg at 90 min at 19°C,
as shown in Fig. 4. Then, in the interval between 90 and 100
min, MPF abruptly and precociously disappears and does not
reappear. This same pattern of a single MPF cycle was found
over a wide range of cycloheximide concentrations (5 to 50
,Lg/ml) and of times ofexposure (0 to 120 min) ofthe oocytes
to the inhibitor before MPF injection. Also, puromycin (50
,ug/ml) and diphtheria toxin (injected at 10 pg/oocyte) had
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FIGURE 5
￿
The time course of meiosis in MPF-injected X. laevis oocytes, as revealed by chromosome morphology. Oocytes were
injected with MPF, then fixed at various times and stained with bisbenzimide (Hoechst 33258 dye). A small patch of the cell
cortex was dissected from the animal pole as described in Materials and Methods, and mounted under a coverslip for visualization
of the fluorescence by epi-illumination. The fluorescent chromosomes were photographed through a 63x Leitz neofluar lens. (A)
80 min after MPF injection; chromosomes are probably in first meiotic prometaphase, inferred from their thickened morphology
and irregular arrangement. (8) 90 min; probable first metiotic metaphase, inferred from the approximately circular arrangement
with the spindle viewed from one end. (C) 100 min; probable first meiotic anaphase. (D) 110 min; probable first meiotic telophase
or interphase. (E) 125 min; possible second meiotic prophase. The first polar body could not be found in these preparations; it
may have been removed with the vitelline membrane during dissection. (F) 140 min; definitive second meiotic metaphase as
inferred from thin chromosomes and tight circular arrangement. The second metaphase is reported to be smaller than the first
metaphase spindle (7). The meiotic figure of the unfertilized egg is identical in appearance to that of F. x 1,000. Bar, 10,um.
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the same effects (data not shown). In a study of the time
course of sensitivity to cycloheximide, we find that the reap-
pearance of MPF is blocked completelyeven when the addi-
tion ofthe inhibitor is delayed untilthe end ofthe first meiotic
period. Once MPF has begun to reappear at 180 min at 19°C,
cycloheximide is no longer able to block its continued ap-
pearance. The transitionto cycloheximide-insensitivityoccurs
abruptly, within 10 min. Thus, we conclude that the oocyte,
even without protein synthesis, can activate MPF almost to
the normal level during the first meiotic cycle, but is unable
to achieve the activation characteristic ofthe second meiotic
cycle.
In an attempt to induce the second cycle of MPF appear-
ance in cycloheximide-treated maturing oocytes, we have
injected MPF a second time (5 units per oocyte) at 90 min
post-GVBD at 19°C. However, no MPF was detectable in
extracts of such oocytes at 210 min post-GVBD; that is, at a
time when noninhibited control oocytes would have shown
high levels of MPF in the second meiotic cycle. Thus, MPF
injections at the time of the second meiotic cycle do not cause
MPF amplification in cycloheximide blocked oocytes,
whereas such injections do so successfully before the first
meiotic cycle. By cytological analysis, we have not been able
to find first or second meiotic metaphase chromosomes in
cycloheximide treated oocytes. Thus, the meiotic maturation
cell cycle seems to stop shortly after GVBD in the presence
of protein synthesis inhibitors. Ziegler and Masui (30) have
reported that protein synthesis is needed for the condensation
of meiotic chromosomes in amphibian oocytes.
DISCUSSION
We have shown that MPF activity cycles in exact correspond-
ence with the M-phase and interphase periods of meiosis in
oocytes and of mitosis in the early cleavages ofthe egg. When
cleavage and spindle formation are interrupted with nocoda-
zole and colchicine, MPF continues to cycle, as do the surface
contraction waves that normally signify the metaphase-ana-
phase transition of mitosis (10). Furthermore, when the cell
cycle is stopped at an interphase stage with cycloheximide,
MPF levels remain low, whereas when it is stopped at meta-
phase with cytostatic factor, MPF levels remain high. Thus,
MPF appears to be closely linked to the oscillatory reactions
driving the cell cycle and not to the "dispensable" events of
cleavage, spindle formation, DNA synthesis, and chromo-
some condensation. This correlation supports the long-stand-
ing suggestion (15, 23) that MPF behaves as a trigger of M-
phase events rather than as an effect of them. From our
studies, we can add three provisions to this suggestion. First,GERHART ET AL .
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activity may be regulated by a still more fundamental and
autonomous cell cycle oscillator. That is to say, MPF may
function at an intermediate level of command between the
oscillatorand the cytologically apparent reactions of mitosis.
Second, MPF is regulated at least in part by a dispensable
event of the first mitotic cell cycle since artificially activated
eggs show an increase of MPF level well in advance (by 0.3
time units) of the increase seen in fertilizedeggs, even though
the surface contraction waves occur at the normal time in
both kinds ofeggs (6). In reciprocal relation to MPF, the MPF
inactivating system must lose activity precociously in acti-
vated eggs. These observations suggest that MPF cycling
becomes partially decoupled from the oscillator in the first
cell cycle. This is the only indication at present that MPF and
the inactivating system are not components of the cell cycle
oscillator itself, but are mediators of its effects. It would be
interesting to distinguish whether precocious appearance of
MPF results from the absence of the sperm centriole (and
microtubule-organizing center) or from the absence of the
sperm nucleus in artificially activated eggs. This could now
be approached by the injection ofpartially purified centrioles
and organizing centers. And as a third provision, it seems that
MPF, even as a mediator ofthe oscillator's effects, must exert
some feedback control on the oscillator, since an injection of
a small amount of MPF into an oocyte causes the cell cycle
to advance from a G2-prophase state to second meiotic met-
aphase of the unfertilized egg. It seems likely that we have
hardly begun to fathom the outlines ofthe cytoplasmic regu-
latory circuits controling these cell cycle events.
We now turn to the question of the mechanism of MPF
activation. A final step of this process may be MPF autoacti-
vation, following the activation of a small threshold amount
of MPF via the cell cycle oscillator. Information about au-
toactivation comes mostly from our studies ofcycloheximide-
treated oocytes. First, it seems clear that GZ arrested oocytes
contain abundant MPF in a latent form that can be activated
by posttranslational mechanisms when a small amount of
active MPF is injected into the oocytes. This posttranslational
mechanism probably drives the autoactivation phase of MPF
activation. A similar conclusion was reached by Doree (2) for
starfish oocytes. We suggest that Drury and Schorderet-Slat-
kine (4) were led to conclude that protein synthesis is needed
for autoactivation ofMPF in amphibian oocytes because they
were unaware of MPF cycling during meiosis and chose to
test oocytes 2 h after MPF injection, a time when cyclohexi-
mide treated oocytes have already destroyed their amplified
MPF of the first meiotic cycle. While we agree with Wasser-
man and Masui (25) that protein synthesis is unnecessary for
MPF autoamplification, we cannot reproduce their finding
that cycloheximide treated oocytes contain transferable levels
of MPF 7 h after they were injected with MPF to initiate
maturation. In our experience, MPF is detectable only within
the first 90 min of maturation in cycloheximide-blocked
oocytes. At latertimes, the oocytes undergo abnormal surface
changes of the sort described by Schuetz and Sampson (22),
and by 7 h they reach a state of discoloration and cytolysis.
There are differences in the experimental proceduresused by
us and by Wasserman and Masui (25), and these may explain
the different asu4s. For example they obtained oocytes from
frogs receiving 10ss'l~-ormonal s bulafiom, and matured them
at a slightly lower temperature(18°C), both procedures caus-
ing slower maturation than in our experiments. In fact, they
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noted that in some cases maturation had not reached GVBD
by 7 h in cycloheximide-treated oocytes, as if the inhibitor
had retarded the rate of maturation still further. Also, they
note that their results were variable; only two of four frogs
gave oocytes that contained MPF at the time of 7 h after
maturationin the presence ofcycloheximide. It seemspossible
that the negative oocytes may have matured more quickly
and destroyed all their MPF by the time ofsampling, or may
have failed to mature by the time of sampling. In any event,
we could not obtain active MPF from our treated oocytes at
such long timesafter maturation.
As a second finding about MPF activity changes, we can
say that oocytes contain abundant reserves of MPF-inactivat-
ing agents in latent form, which, like MPF, are activated by
posttranslational processes when MPF is injected in small
amounts. These inactivating agents operate shortly after
GVBD, that is, approximately on schedule at the end of the
first meiotic cycle even in cycloheximide treated oocytes. A
similar conclusion applies to unfertilized eggs: they too must
contain latent MPF-inactivating agents, which are activated
by posttranslational means at fertilization.
A third finding from these studies is that cycloheximide-
blocked oocytes fail to activate MPF at the time ofthe second
meiotic cycle. In a parallel situation, unfertilized eggs treated
with cycloheximide fail to activate MPF for the first mitotic
cycle after egg activation. There are various possibilities for
this failure; foremost among these, the cell cycle may be
stopped by cycloheximide and may never advance to the
point where MPF would be activated. In fact, we anticipate
this to be the case since cycloheximide is known to prevent
the cyclic appearance of the surface contraction waves nor-
mally occurring at metaphase of activated enucleated eggs
(18). If the cell cycle does not advance, the oocyte or egg
might then lack the primary stimulus to activate a small
amount of latent MPF, and so MPF would never reach its
autoactivating phase. Also, ifthe cell cycle is arrested, perhaps
the MPF-inactivating system is itself never destroyed, and
would continue to oppose MPF-activation. We favor this
possibility since we find in preliminary experiments that high
levels of MPF are rapidly destroyed when injected into cyclo-
heximide-treated oocytes 90 min after GVBD, that is, at a
time when these treated oocytes continue to lack endogenous
MPF activity, whereas control oocytes would have acquired
MPF activity in the second meiotic cycle. As a finalpossibility,
cycloheximide-treated maturing oocytes may not be able to
activate MPF in the second meiotic cycle, for lack of MPF
precursor. This would be the case ifMPF is regularly proteo-
lyzed in the course of each cyclic inactivation, and then
activated from newly synthesized precursor material. Unfor-
tunately, the continued presence ofthe strong MPF inactivat-
ing system in cycloheximide-treated oocytes after GVBD
precludes our testing ofthis possibility.
In conclusion, we have attempted to view the cell cycle of
the oocyte and cleaving egg as basically the same, driven by
an endogenous oscillator that depends on protein synthesis
for its regular cycling, but does not depend on the "dispensa-
ble" elements of the cycle, such as DNA synthesis, chromo-
some condensation, spindle formation, and cleavage. We look
on the nonmatured oocyte as a specialized case where the
oscillator is blocked in the late G$ phase by an arrest system,
which me-be ne4trál xed by aprogçs rone-dependent release
mechanism, as has been proposed by Mailer and Krebs (13).
The arrest system would be specific to those few cell types,such as the oocyte, that arrest in the G2 phase, whereas the
progesterone-dependent release system might be specific to
the oocytes of amphibia. In contrast, the oscillatoris likely to
be general to all meiotic and mitotic cell cycles. After release,
the oscillator would progress to the point of stimulating MPF
activation. Then MPF autoactivation would take over, and
the cytological events of maturation would follow as a result
ofthe MPF Stimulus. However, ifprotein synthesis is blocked,
the oscillator cannot advance, and therefore MPF activation
cannot occur. Despite this, if active MPF is injected, the
dependence on the oscillator can be bypassed, and MPF is
activated directly. According to this model, protein synthesis
would not be needed for the progesterone-dependent release
system, as has been proposed (12, 13), but for the advance of
the cell cycle to the point of MPF activation. Then, when the
maturing oocyte reaches second meiotic metaphase, as an
unfertilized egg, another specialized arrest system appears;
namely, the cytostatic factor that blocks the cell cycle at
metaphase, a stage where MPF activity is high and the MPF-
inactivating system is suppressed. Fertilization or activation
removes this arrest, and MPF is inactivated. Thereafter the
oscillator is free to cycle 12 times on a regular 30 min schedule
of M and S phases until the midblastula transition occurs
(20). At this time the cell cycle becomes slower and more
complex, and MPF activity presumably comes under new
cellular controls.
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